| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |